Apollo Hospitals Enterprise Ltd. (AHEL) on Friday announced that it will acquire the 31% stake held by International Finance Corporation (IFC) in Apollo Health and Lifestyle Limited (AHLL), for a consideration of ₹1,254 crore.
Once the transaction is completed, AHLL will become a 100% subsidiary of AHEL, with 99.42% held by AHEL and the balance in the ESOP pool. The acquisition is expected to close by the end of November 2025, subject to regulatory approvals and customary closing formalities.
Management on the acquisition
Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise Ltd., said:
“This acquisition is a decisive step that will allow for sharper capital allocation and a greater focus on select high-potential segments. With disciplined growth, improved profitability, and enhanced return on capital employed (ROCE), we see AHLL becoming a value-accretive driver in Apollo’s integrated healthcare portfolio.”
Sangita Reddy, Joint Managing Director, added:
“By bringing AHLL fully into Apollo’s fold, we are sharpening the business focus across its four verticals – primary care and diagnostics, birthing and women’s health, ambulatory care, and dialysis and dental. This sharper focus will enable AHLL to scale more effectively, innovate faster, and serve patients with care models that are more personalised, accessible, and future-ready.”
Expansion in Gurugram
Apollo Hospitals also announced plans to set up a 100-bed comprehensive oncology centre in Gurugram, as part of the Phase 2 expansion of its upcoming 500-bed hospital in the city. The Phase 1 development is on track for commissioning by end-Q4 FY25 or Q1 FY26, while the Proton and Integrated Cancer Centre will be completed over the next four years.
